Risk Profile | FDA Authorizes Zyn But Keeps Vapes in Limbo | RegWatch
March 11, 2025 by regulatorwatch.com
Risk Profile | FDA Authorizes Zyn But Keeps Vapes in Limbo | RegWatch
Earlier this year, the U.S. Food and Drug Administration granted marketing orders for 20 Zyn flavored nicotine pouch products—the first time the agency has authorized such products. The decision left many in the vaping world stunned—not just by the range of flavors greenlit, from cinnamon and citrus to coffee and peppermint—but by the FDA’s continued foot-dragging on e-cigarette approvals. Why the disparity when both pouches and vapes are considered safer nicotine alternatives? Joining us to break it all down is Kevin Schroth, J.D., Associate Professor at Rutgers School of Public Health and the Institute for Nicotine and Tobacco Studies.
